从非结构化的EHR中对肺癌的整体生存预测进行分层嵌入注意力
Domenico Paolo1, Carlo Greco2,3, Alessio Cortellini4
1Unit of Computer Systems & Bioinformatics, Department of Engineering, University Campus Bio-Medico di Roma, Roma, Italy.
BMC medical informatics and decision making
|April 18, 2025
概括
这项研究使用先进的自然语言处理 (NLP) 来从电子健康记录 (EHR) 中提取丰富的信息,以预测癌症存活率. 该方法通过利用学习的表示来改善临床预测,优于传统的特征提取.
科学领域:
- 计算语言学计算语言学
- 医疗信息学医学信息学
- 在瘤学瘤学.
背景情况:
- 电子健康记录 (EHR) 包含非结构化数据,对临床见解有价值.
- 自然语言处理 (NLP) 和命名实体识别 (NER) 是从EHR中提取信息的关键.
- 现有的方法往往忽略了NLP模型的学习表征.
研究的目的:
- 探索基于变压器的NER模型在EHR中的学习表示的潜力.
- 开发一种增强的临床预测模型,使用这些表示用于非小细胞肺癌 (NSCLC) 的整体存活率 (OS).
- 证明拟议方法的可解释性.
主要方法:
- 从一个基于变压器的NER模型中提取的表示,应用于意大利的EHR.
- 使用层次关注机制的组合实体表示.
- 利用丰富的表示作为NSCLCOS的临床预测模型的输入.
- 通过专家协议对突出显示的EHR信息进行验证的解释性.
主要成果:
- 与传统方法相比,使用丰富的EHR表示的拟议方法在预测非小细胞肺癌 (NSCLC) 的整体存活率 (OS) 中显示了统计学上显著的改进.
- 层次的注意力机制为预测提供了对关键EHR信息的可解释的见解.
- 专家验证证实了注意力机制突出显示的信息的相关性.
结论:
- 从NLP模型中学习的表示提供了使用非结构化EHR数据进行临床预测的强大方法.
- 层次关注机制提高了预测准确性和模型可解释性.
- 这种方法为分析EHR和推进癌症研究提供了有价值的工具.
更多相关视频
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.1K
03:14Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
Published on: December 6, 2024
462
相关概念视频
Cancer Survival Analysis
298
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
298
Kaplan-Meier Approach
55
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
55
